Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of clinical outcomes of anidulafungin for the treatment of candidemia in hospitalized critically ill patients with obesity: A multicenter, retrospective cohort study.
Alsowaida YS, Sulaiman KA, Mahrous AJ, Alharbi A, Bifari N, Alshahrani WA, Almangour TA, Damfu N, Banamah AA, Raya RRA, Sadawi RA, Alharbi A, Alsolami A, Essa Y, Almagthali AG, Alhejaili SF, Qawwas WA, Alharbi GS, Alkeraidees AS, Alshomrani A, Aljohani MA, Aljuhani O. Alsowaida YS, et al. Among authors: almagthali ag. Int J Infect Dis. 2024 Nov;148:107234. doi: 10.1016/j.ijid.2024.107234. Epub 2024 Sep 4. Int J Infect Dis. 2024. PMID: 39241957 Free article.
The Predictors and Risk Factors of 2-Year Rejection in Renal Transplant Patients: A Multicenter Case-Control Study.
Alsulami MM, Al-Otaibi NE, Alshahrani WA, Altheaby A, Al Thiab KM, Alnajjar LI, Albekery MA, Almutairy RF, Asiri MY, AlMohareb SN, Alsehli FA, Binthuwaini AT, Almagthali A, Alwaily SS, Alzahrani AY, Alrohile F, Alqurashi AE, Alshareef H, Almarhabi H, Alharbi A, Alrashidi H, Alamri RM, Alnahari FN, Mohsin B, Odah NO, Habhab WT, Alfi YA, Alhaidal HA, Alghwainm M, Al Sulaiman K. Alsulami MM, et al. Among authors: almagthali a. Am J Nephrol. 2024;55(4):487-498. doi: 10.1159/000538963. Epub 2024 Apr 26. Am J Nephrol. 2024. PMID: 38679014
The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study.
Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi AF, Vishwakarma R, AlFaifi M, Alsohimi S, Alrayes A, Albishi S, Alqahtani R, Alalawi M, Al Sulaihim I, Alanazi TA, Alqahtani RA, Almagthali A, Jomah S, Alshlowi A, Alshammari TR, Alzahrani SS, Abdulqader MI. Al Sulaiman K, et al. Among authors: almagthali a. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231218216. doi: 10.1177/10760296231218216. Clin Appl Thromb Hemost. 2023. PMID: 38073058 Free PMC article.
When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study.
Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi AF, AlFaifi M, Nahari M, Almagthali A, Thabit AK, Alhajaji R, Alharbi R, Kahtani K, Alenazi AA, Alharbi A, Alghwainm MM, Alotaibi SM, Alghamdi YS, Alotaibi S, Alonazi SH, Almutairi JM, Vishwakarma R. Al Sulaiman K, et al. Among authors: almagthali a. J Infect Public Health. 2023 Sep;16(9):1492-1499. doi: 10.1016/j.jiph.2023.06.011. Epub 2023 Jun 14. J Infect Public Health. 2023. PMID: 37355406 Free PMC article.
Doxycycline's Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study.
Al Sulaiman K, Aljuhani O, Korayem GB, Alnajjar LI, Altebainawi AF, AlFaifi M, Vishwakarma R, Alenazi AA, Alalawi M, Alissa A, Alsowaida YS, Alsohimi S, Almagthali A, Alay SM, Altaher N, Alamri MG, Alangari D, Alzahrani A, Abdul Razack HI, Alhamoud J, Alshaya A, Gramish J, Al Aamer K, Alsaeedi AS, Alghamdi G. Al Sulaiman K, et al. Among authors: almagthali a. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231177017. doi: 10.1177/10760296231177017. Clin Appl Thromb Hemost. 2023. PMID: 37322869 Free PMC article.
Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
Al Sulaiman K, Korayem GB, Altebainawi AF, Al Harbi S, Alissa A, Alharthi A, Kensara R, Alfahed A, Vishwakarma R, Al Haji H, Almohaimid N, Al Zumai O, Alrubayan F, Asiri A, Alkahtani N, Alolayan A, Alsohimi S, Melibari N, Almagthali A, Aljahdali S, Alenazi AA, Alsaeedi AS, Al Ghamdi G, Al Faris O, Alqahtani J, Al Qahtani J, Alshammari KA, Alshammari KI, Aljuhani O. Al Sulaiman K, et al. Among authors: almagthali a. Crit Care. 2022 Oct 3;26(1):304. doi: 10.1186/s13054-022-04158-y. Crit Care. 2022. PMID: 36192801 Free PMC article.
Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study.
Al Sulaiman K, Aljuhani O, Bin Salah K, Korayem GB, Eljaaly K, Al Essa M, Kharbosh A, Al Harbi F, Abuzaid M, Al Bilal S, Almagthali A, Alsohemi S, Alshabasy A, Noureldeen H, Aboudeif M, Alshehri A, Vishwakarma R. Al Sulaiman K, et al. Among authors: almagthali a. J Crit Care. 2021 Dec;66:44-51. doi: 10.1016/j.jcrc.2021.08.007. Epub 2021 Aug 23. J Crit Care. 2021. PMID: 34438133 Free PMC article.